AzTrials
AzTrials

Quality of LifeQoLNMDNCT02895763

Quality of Life in Neuromuscular Disease

An observational study of Quality of Life and Muscular Dystrophies, run by CHU de Reims at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A Quality work was conducted to enable the future construction of a Quality of Life Questionnaire Related to Health (HRQoL) in patients with slowly progressive neuromuscular disease (NMD) as myopathies and muscular dystrophies. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Quality of Life, Muscular Dystrophies
What is being tested?
Form administrations
How many people
159 participants
Where
1 siteFrance
Study dates
Jun 2006to Jun 2013
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: French Patients, young adults and adults, with a diagnosed neuromuscular disease, of any known form.

Who may be able to join

  • Patient with neuromuscular disease

Who cannot join

  • <18 yo

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chu de Reims

    Reims, France, 51092

Other trials in France

About this study

Official title: Development of a New Scale of Quality of Life, Specific of Neuro Muscular Diseases and More Specifically of Steinert Disease, by the Rasch Model Methods.

A Quality work was conducted to enable the future construction of a Quality of Life Questionnaire Related to Health (HRQoL) in patients with slowly progressive neuromuscular disease (NMD) as myopathies and muscular dystrophies. The discussion group training is an effective method to perform a thorough investigation of aspects of HRQoL potentially altered by NMD. Patients were recruited in France by 4 reference centers MNMs. All verbal interactions between participants focus groups were recorded. A qualitative analysis of the transcript was performed. The transcript provided 2424 CIF categories. The results helped to identify and quantify aspects of life that are altered by NMDs between patients. A pool of 64 items and a validated questionnaire (the WHOQOLBREF) were thern passed by 159 patients enrolled in eight reference centers MNMs. The investigators constructed a questionnaire called QoLNMD which is composed of two general items and 24 items classified into three areas: (1) \ Impact bodily symptoms, "(2) \ Self-perception" and (3) \ Activity participation. "Each area has good psychometric properties (Cronbach's alpha> 0.77, test-retest ICC> 0.81, H Loevinger> 0.41) and met the assumptions of IRT. the comparison with the WHOQOL-BREF was used to assess similarities and differences with a generic questionnaire. The next step was to validate the QoLNMD reassessing its psychometric properties in a new patient sample and calibrate the IRT measurement system. The purpose of these new part of study was to validate the French version of the QoL-NMD on a confirmatory sample of patients and to calibrate its measurement system. A prospective study in 8 NMD referral centers (France) was conducted. Both the QoL-NMD and a validated generic questionnaire (the WHOQOLBREF) were administered to patients. 156 patients were included for the confirmatory psychometric analysis. All three domains showed adequate psychometric properties and met IRT assumptions. The IRT model calibration was then performed successfully on 315 patients. The French version of the QoL-NMD showed adequate psychometric properties and can be used in rehabilitation services. A conversion table enables easy transformation of sum scores into IRT-calibrated measures. Minimum detectable change tables help interpreting score change.

Read the detailed description

Quality work was conducted to enable the future construction of a Quality of Life Questionnaire Related to Health (HRQoL) in patients with slowly progressive neuromuscular disease (NMD) as myopathies and muscular dystrophies.

The discussion group training is an effective method to perform a thorough investigation of aspects of HRQoL potentially altered by NMD. Patients were recruited in France by 4 reference centers NMDs. To ensure that the performance in terms of severity would be adequate, three focus groups were formed: (1) Patients capable of walking. (2) Patients in wheelchairs. (3) Patients in wheelchairs and requiring continue ventilatory support. All verbal interactions between participants focus groups were recorded. A qualitative analysis of the transcript was performed according to the framework of the International Classification of Functioning, Disability and Health (ICF).

A total of 41 patients divided into five discussion groups were interviewed. The transcript provided 2424 ICF categories. References to percentages of different categories ICF were calculated and graphed.

The results helped to identify and quantify aspects of life that are altered by MNMs between patients. This qualitative work was the first phase of the ambitious project to develop a new specific questionnaire for NMDs HRQoL.

Build a questionnaire for assessing the quality of health-related life (HRQoL) in patients with NMD using item response theory (IRT).

A pool of 64 items and a validated questionnaire (the WHOQOLBREF) were passed by 159 patients enrolled in eight reference centers MNMs. The exploratory analysis included statistical methods derived from both the TRI and classical test theory.

The investigators constructed a questionnaire called QoLNMD which is composed of two general items and 24 items classified into three areas: (1) \ Impact bodily symptoms, "(2) \ Self-perception" and (3) \ Activity participation. "Each area has good psychometric properties (Cronbach's alpha> 0.77, test-retest ICC> 0.81, H Loevinger> 0.41) and met the assumptions of IRT. the comparison with the WHOQOL-BREF was used to assess similarities and differences with a generic questionnaire.

This study has allowed the development of a new HRQL questionnaire specifically designed for patients with MNM. The QoLNMD is short enough to be used in clinical practice (26 items).

The next step was to validate the QoLNMD reassessing its psychometric properties in a new patient sample and calibrate the IRR measurement system. The purpose of these new part of study was to validate the French version of the QoL-NMD on a confirmatory sample of patients and to calibrate its measurement system.

A prospective study in 8 NMD referral centers (France) was conducted. Both the QoL-NMD and a validated generic questionnaire (the WHOQOLBREF) were administered to patients. Confirmatory psychometric analyses were performed on the new sample while the Items Response Theory (IRT) model calibration was performed on all patients ever recruited using the Partial Credit Model (Rasch).

156 patients were included for the confirmatory psychometric analysis. All three domains showed adequate psychometric properties (internal consistency: repeatability ; scalability) and met IRT assumptions. The IRT model calibration was performed successfully on 315 patients. Minimum detectable change estimates are distribution based and should be verified by external meaningful anchors.

Being tested
Form administrations
Keywords
QUALITY OF LIFE, NEUROMUSCULAR DISEASES
Medical subject headings
Muscular Dystrophies, Neuromuscular Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Form administrationsOther

Study groups in NCT02895763
Study groupRoleWhat they receive
Neuro Muscular disease patientsFrench Patients, young adults and adults, with a diagnosed neuromuscular disease, of any known form.
Receives: Other: Form administrations

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self reported form of items measuring the Quality of Life

    The Quality of Life questionnaire used is QoLNMD

    Measured: 0 month

Secondary outcomes (2)
  1. Self reported form of items measuring the Quality of Life

    The Quality of Life questionnaire used is QoLNMD

    Measured: 6 months

  2. Self reported form of items measuring the Quality of Life

    The Quality of Life questionnaire used is QoLNMD

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Sep 2016 (estimated)
  2. Study startJun 2006
  3. Primary completionDec 2012
  4. Study completionJun 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
159 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02895763
Sponsor's protocol ID
2015Ao005
Acronym
QoLNMD
Status last verified
Sep 2016
First submitted
18 Aug 2016
Last updated
23 Sep 2016
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Quality of Life and Muscular Dystrophies, run by CHU de Reims at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self reported form of items measuring the Quality of Life (time frame: 0 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in